Diagnostics News and Research

RSS

Novel approach accelerates cancer biomarker detection in point-of-care scenarios

The detection and quantification of cancer-associated molecular biomarkers in body fluids, or liquid biopsies, prove minimally invasive in early cancer diagnostics.

31 Jan 2022

RNA sequencing picks up more genetic changes in pediatric cancer patients than traditional tests

Analysis of the entire tumor RNA picks up more clinically relevant genetic changes in children with cancer than traditional diagnostic methods, new research has shown.

28 Jan 2022

Scientists discover families of proteins that could predict organ transplant rejection

Northwestern University scientists have discovered families of proteins in the body that could potentially predict which patients may reject a new organ transplant, helping inform decisions about care.

28 Jan 2022

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

MIP Diagnostics Ltd. has today announced that its synthetic SARS-CoV-2 antibody (COVID-19 nanoMIPTM) can detect the Omicron variant as well as previously proven Alpha, Beta, Delta and Gamma variants of the COVID-19 virus.

14 Jan 2022

The Native Antigen Company Expands Range of Norovirus-Like Particles

The Native Antigen Company today announced the expansion of its norovirus-like particle range, with the addition of six new reagents.

From The Native Antigen Company 13 Jan 2022

Fluidlab; Combining Cell Counting and Spectrometry to Improve Fluid Analysis

In this interview, we speak to David Heinz from anvajo about their fluidlab technology that combines cell counting and spectrometry to improve fluid analysis.

From anvajo 11 Jan 2022

New high-quality assay can be used in at-home tests for rapid COVID-19 screening

Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening.

4 Jan 2022

INTEGRA supports groundbreaking brain tumor research

INTEGRA Biosciences is proud to be supporting vital translational research into diffuse intrinsic ponsglioma (DIPG) – a rare childhood brain tumor – at the Ludwig Maximilian University of Munich (LMU) with a festive donation of 20,000 EUR.

From INTEGRA Biosciences 21 Dec 2021

New method combines AI and microfluidics to easily barcode individual cells

An innovative new method for more efficient and accurate barcoding of individual cells could help realize faster diagnosis of diseases.

From University of Exeter 21 Dec 2021

INTEGRA offers answers to your cell culture throughput needs

With INTEGRA electronic pipettes, you can program and store pipetting protocols and mixing routines for use across various workflows.

From INTEGRA Biosciences 14 Dec 2021

Study details the design of RNA-based breathalyzer to diagnose SARS-CoV-2

In a new study in The Journal of Molecular Diagnostics, published by Elsevier, investigators report on the design and testing of a breathalyzer, known as the Bubbler, that relies on viral RNA detection to diagnose SARS-CoV-2. Its name is derived from the bubbling sound that occurs when the patient exhales into the device.

14 Dec 2021

Powering the Biotechnology Revolution through Cloud R&D

In this interview, we speak to Sajith Wickramasekara, CEO and Co-Founder of Benchling, about cloud R&D and how it is powering the biotechnology revolution.

From Benchling 10 Dec 2021

First molecular structure of TDP-43 could pave the way for new ALS therapies

Scientists have determined for the first time the structure of the molecule associated with amyotrophic lateral sclerosis (ALS) and multiple other neurodegenerative diseases.

9 Dec 2021

Resolve Biosciences Appoints Oliver Dick as Chief Operating Officer

Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the appointment of Oliver Dick, PhD, as Chief Operating Officer.

From Resolve Biosciences 6 Dec 2021

Automate your sample pooling with INTEGRA’s efficient pipetting solutions

INTEGRA’s automated pipetting solutions are helping scientists meet the challenge of efficiently pooling potentially infectious samples prior to testing.

From INTEGRA Biosciences 3 Dec 2021

New microchip to grow DNA strands could provide high-density 3D archival data storage

Researchers have made significant advances toward the goal of a new microchip able to grow DNA strands that could provide high-density 3D archival data storage at ultra-low cost – and be able to hold that information for hundreds of years.

2 Dec 2021

Cancer data available for global scientists through Microsoft’s Azure

The International Cancer Genome Consortium (ICGC) is further enhancing cancer research globally by constructing a huge collection of cancer data.

25 Nov 2021

Cerba Research Expands U.S. Immuno-Oncology Center of Excellence to Strengthen Its Precision Medicine Offerings

Cerba Research recently expanded. Our U.S. Immuno-Oncology Center of Excellence allows us to provide even more comprehensive, integrated central lab services, specialty lab and biomarker solutions, and diagnostic services worldwide.

25 Nov 2021

Simplifying PCR set-up with INTEGRA’s range of pipettes

INTEGRA Biosciences’ selection of liquid handling tools provides scientists worldwide with the solutions they need for their PCR workflows.

From INTEGRA Biosciences 23 Nov 2021

Biognosys Launches Next-Generation Blood Biomarker Discovery Solution

Biognosys today announces the launch of its next-generation blood biomarker discovery solution, which will be offered as a contract research service.

From Biognosys 10 Nov 2021